Recent advances in siRNA delivery mediated by lipid-based nanoparticles

被引:278
作者
Yonezawa, Sei [1 ]
Koide, Hiroyuki [1 ]
Asai, Tomohiro [1 ]
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan
基金
日本学术振兴会;
关键词
Lipid nanoparticles; siRNA; pH-responsive ionizable lipid; SERUM LDL-CHOLESTEROL; SMALL INTERFERING RNA; MANTLE CELL LYMPHOMA; NIEMANN-PICK C1; IN-VIVO; LIPOSOMAL NANOPARTICLES; INTRACELLULAR DELIVERY; NONHUMAN-PRIMATES; SUSTAINED-RELEASE; UPTAKE MECHANISM;
D O I
10.1016/j.addr.2020.07.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Small interfering RNA (siRNA) has been expected to be a unique pharmaceutic for the treatment of broadspectrum intractable diseases. However, its unfavorable properties such as easy degradation in the blood and negative-charge density are still a formidable barrier for clinical use. For disruption of this barrier, siRNA delivery technology has been significantly advanced in the past two decades. The approval of Patisiran (ONPATTROTM) for the treatment of transthyretin-mediated amyloidosis, the first approved siRNA drug, is a most important milestone. Since lipid-based nanoparticles (LNPs) are used in Patisiran, LNP-based siRNA delivery is now of significant interest for the development of the next siRNA formulation. In this review, we describe the design of LNPs for the improvement of siRNA properties, bioavailability, and pharmacokinetics. Recently, a number of siRNA encapsulated LNPs were reported for the treatment of intractable diseases such as cancer, viral infection, inflammatory neurological disorder, and genetic diseases. We believe that these contributions address and will promote the development of an effective LNP-based siRNA delivery system and siRNA formulation. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:64 / 78
页数:15
相关论文
共 208 条
[1]   Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].
Abifadel, M ;
Varret, M ;
Rabès, JP ;
Allard, D ;
Ouguerram, K ;
Devillers, M ;
Cruaud, C ;
Benjannet, S ;
Wickham, L ;
Erlich, D ;
Derré, A ;
Villéger, L ;
Farnier, M ;
Beucler, I ;
Bruckert, E ;
Chambaz, J ;
Chanu, B ;
Lecerf, JM ;
Luc, G ;
Moulin, P ;
Weissenbach, J ;
Prat, A ;
Krempf, M ;
Junien, C ;
Seidah, NG ;
Boileau, C .
NATURE GENETICS, 2003, 34 (02) :154-156
[2]   Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy [J].
Adesina, Simeon K. ;
Akala, Emmanuel O. .
MOLECULAR PHARMACEUTICS, 2015, 12 (12) :4175-4187
[3]   A combinatorial library of lipid-like materials for delivery of RNAi therapeutics [J].
Akinc, Akin ;
Zumbuehl, Andreas ;
Goldberg, Michael ;
Leshchiner, Elizaveta S. ;
Busini, Valentina ;
Hossain, Naushad ;
Bacallado, Sergio A. ;
Nguyen, David N. ;
Fuller, Jason ;
Alvarez, Rene ;
Borodovsky, Anna ;
Borland, Todd ;
Constien, Rainer ;
de Fougerolles, Antonin ;
Dorkin, J. Robert ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
John, Matthias ;
Koteliansky, Victor ;
Manoharan, Muthiah ;
Nechev, Lubomir ;
Qin, June ;
Racie, Timothy ;
Raitcheva, Denitza ;
Rajeev, Kallanthottathil G. ;
Sah, Dinah W. Y. ;
Soutschek, Juergen ;
Toudjarska, Ivanka ;
Vornlocher, Hans-Peter ;
Zimmermann, Tracy S. ;
Langer, Robert ;
Anderson, Daniel G. .
NATURE BIOTECHNOLOGY, 2008, 26 (05) :561-569
[4]   Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms [J].
Akinc, Akin ;
Querbes, William ;
De, Soma ;
Qin, June ;
Frank-Kamenetsky, Maria ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
Rajeev, Kallanthottathil G. ;
Cantley, William L. ;
Dorkin, J. Robert ;
Butler, James S. ;
Qin, LiuLiang ;
Racie, Timothy ;
Sprague, Andrew ;
Fava, Eugenio ;
Zeigerer, Anja ;
Hope, Michael J. ;
Zerial, Marino ;
Sah, Dinah W. Y. ;
Fitzgerald, Kevin ;
Tracy, Mark A. ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
de Fougerolles, Antonin ;
Maier, Martin A. .
MOLECULAR THERAPY, 2010, 18 (07) :1357-1364
[5]   Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery [J].
Akita, Hidetaka ;
Noguchi, Yuki ;
Hatakeyama, Hiroto ;
Sato, Yusuke ;
Tange, Kota ;
Nakai, Yuta ;
Harashima, Hideyoshi .
ACS BIOMATERIALS SCIENCE & ENGINEERING, 2015, 1 (09) :834-844
[6]   Effect of hydrophobic scaffold on the cellular uptake and gene transfection activities of DNA-encapsulating liposomal nanoparticles via intracerebroventricular administration [J].
Akita, Hidetaka ;
Nakatani, Taichi ;
Kuroki, Kimiko ;
Maenaka, Katsumi ;
Tange, Kota ;
Nakai, Yuta ;
Harashima, Hideyoshi .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 490 (1-2) :142-145
[7]   A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma [J].
Akita, Hidetaka ;
Ishiba, Ryohei ;
Togashi, Ryohei ;
Tange, Kota ;
Nakai, Yuta ;
Hatakeyama, Hiroto ;
Harashima, Hideyoshi .
JOURNAL OF CONTROLLED RELEASE, 2015, 200 :97-105
[8]   A Neutral Envelope-Type Nanoparticle Containing pH-Responsive and SS-Cleavable Lipid-Like Material as a Carrier for Plasmid DNA [J].
Akita, Hidetaka ;
Ishiba, Ryohei ;
Hatakeyama, Hiroto ;
Tanaka, Hiroki ;
Sato, Yusuke ;
Tange, Kota ;
Arai, Masaya ;
Kubo, Kazuhiro ;
Harashima, Hideyoshi .
ADVANCED HEALTHCARE MATERIALS, 2013, 2 (08) :1120-1125
[9]   Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation [J].
Akita, Hidetaka ;
Kogure, Kentaro ;
Moriguchi, Rumiko ;
Nakamura, Yoshio ;
Higashi, Tomoko ;
Nakamura, Takashi ;
Serada, Satoshi ;
Fujimoto, Minoru ;
Naka, Tetsuji ;
Futaki, Shiroh ;
Harashima, Hideyoshi .
JOURNAL OF CONTROLLED RELEASE, 2010, 143 (03) :311-317
[10]   Exploring PAZ/3′-overhang interaction to improve siRNA specificity. A combined experimental and modeling study [J].
Alagia, Adele ;
Jorge, Andreia F. ;
Avino, Anna ;
Cova, Tania F. G. G. ;
Crehuet, Ramon ;
Grijalvo, Santiago ;
Pais, Alberto A. C. C. ;
Eritja, Ramon .
CHEMICAL SCIENCE, 2018, 9 (08) :2074-2086